Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma.
Armando SantoroAlison J MoskowitzSilvia FerrariCarmelo Carlo-StellaJulie M LisanoStephen FrancisRachael WenAlev AkyolKerry Joane SavagePublished in: Blood (2023)